EUVIMEDEUVIMED entdecken
Crossref

Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in rats

Zerrin Kutlu iD, Zekai Halici iD, Fatih Alper iD, Erdem Toktay iD, Adem Maman iD, Hamza Halici iD, Zafer Bayraktutan iD, Ahmet Yalcin iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Zerrin Kutlu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Ataturk University, Erzurum 25240, Turkey. Hauptthemen laut MEDLINE: Eye Proteins, Serpins, Receptors, Prostaglandin E, EP2 Subtype, Osteoporosis. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Presidency of the Turkish Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study investigated the effects of pigment epithelium-derived factor (PEDF) on bone homeostasis in a glucocorticoid-induced osteoporosis (GIOP) rat model, focusing on prostaglandin E2 receptors EP2 and EP4.

Methods

Male Sprague–Dawley rats were divided into six groups. Dexamethasone (DEX, 1 mg/kg) was administered intramuscularly twice weekly for 90 days to induce osteoporosis. PEDF (50, 100, 200 mg/kg) was then given subcutaneously for 30 days. Bone mineral density (BMD) and bone morphology were assessed by computed tomography. Bone turnover markers—C-terminal telopeptide of type I collagen (CTX-1), tartrate-resistant acid phosphatase 5b (TRAP-5b), and bone-specific alkaline phosphatase—as well as EP2/EP4 mRNA expressions were evaluated using qRT-PCR. Key findings Immunohistochemical analysis was performed for ALP, osteopontin, osteocalcin, and VEGFR1. PEDF partially mitigated DEX-induced weight loss and dose-dependently restored BMD. Histopathological analyses showed improved bone architecture in all PEDF-treated groups. PEDF increased bone formation markers, reduced bone resorption markers, and upregulated EP2/EP4 expression.

Conclusion

These findings indicate that PEDF exerts protective effects against GIOP and may modulate bone metabolism through EP2/EP4 signalling pathways. PEDF shows promise as a potential therapeutic agent for preventing bone loss in GIOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye ProteinsSerpinsReceptors, Prostaglandin E, EP2 SubtypeOsteoporosisNerve Growth FactorsReceptors, Prostaglandin E, EP4 SubtypeAnimalsRats, Sprague-DawleyMaleGlucocorticoidsBone DensityRatsDexamethasoneDisease Models, AnimalDose-Response Relationship, DrugBone Remodeling

Stichwörter der Autor:innen

CTX-1EP2 and EP4 receptorsP1NPPEDFglucocorticoidsosteoporosis

Substanzen

Eye ProteinsSerpinsReceptors, Prostaglandin E, EP2 SubtypeGlucocorticoidsNerve Growth FactorsReceptors, Prostaglandin E, EP4 SubtypeDexamethasonePtger4 protein, rat

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Ataturk University, Erzurum 25240, Turkey.
  • Department of Internal Medical Sciences, Division of Medical Pharmacology, Ataturk University Faculty of Medicine, Erzurum 25240, Turkey.
  • Department of Internal Medical Sciences, Division of Medical Radiology, Ataturk University Faculty of Medicine, Erzurum 25240, Turkey.
  • Department of Basic Medical Sciences, Division of Histology and Embrology, Kafkas University Faculty of Medicine, Kafkas 36100, Turkey.
  • Department of Internal Medical Sciences, Division of Nuclear Medicine, Ataturk University Faculty of Medicine, Erzurum 25240, Turkey.
  • Department of Pharmacy Services, Atatürk University Hınıs Vocational School, Erzurum 25240, Turkey.

ORCID-Profile: Zerrin Kutlu, Zekai Halici, Fatih Alper, Erdem Toktay, Adem Maman, Hamza Halici, Zafer Bayraktutan, Ahmet Yalcin

Förderung

  • Presidency of the Turkish Institutes of Health

Zitieren

APA

Kutlu, Z., Halici, Z., Alper, F., Toktay, E., Maman, A., Halici, H., Bayraktutan, Z., & Yalcin, A. (2026). Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf102

Vancouver

Kutlu Z, Halici Z, Alper F, Toktay E, Maman A, Halici H, et al. Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in rats. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf102

BibTeX
@article{Kutlu2026,
  author = {Kutlu, Zerrin and Halici, Zekai and Alper, Fatih and Toktay, Erdem and Maman, Adem and Halici, Hamza and Bayraktutan, Zafer and Yalcin, Ahmet},
  title = {Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in rats},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf102}
}
Kostenlos starten →